A PILOT PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (hypo-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) Meeting Abstract (Web of Science)

cited authors

  • Ney, Douglas; Carlson, Julie; Damek, Denise; Blatchford, Patrick; Gaspar, Laurie; Kavanagh, Brian; Waziri, Allen; Lillehei, Kevin; Reddy, Krishna; Chen, Changhu

publication date

  • November 1, 2013

webpage

published in

category

start page

  • 80

end page

  • 81

volume

  • 15